Daiwa Securities Group Inc.

Broker-Dealer

Position in CGC — Canopy Growth Corp

CIK 1481045 CHIYODA-KU,TOKYO, M0

Back to CGC Full portfolio

Position in CGC

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$114,639

+$98,793 QoQ

Shares Held

120,800

+769.1% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CGC Over Time

Shares Held

Position Value (USD)

Derivatives in CGC

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

PutValue

$114,639

PutShares

120,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Daiwa Securities Group Inc. holds $24,604,001 across 9 Drug Manufacturers - Specialty & Generic names. CGC ranks #8 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	99,602	$11,773,951
2	UTHR	UNITED THERAPEUTICS Corp	6,334	$3,755,934
3	TEVA	Teva Pharmaceutical Industries Ltd	105,965	$3,191,665
4	NBIX	Neurocrine Biosciences Inc	22,485	$2,962,173
5	VTRS	Viatris Inc	138,280	$1,868,162
6	ALKS	Alkermes plc.	13,400	$473,824
7	LNTH	Lantheus Holdings, Inc.	5,538	$420,057
8	CGC	Canopy Growth Corp This page	120,800	$114,639

All Filings in CGC

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$114,639	120,800	0.0%	Shares	Defined	2026-05-13
2026-03-31	$114,639	120,800	+769.1%	Put	Defined	2026-05-13
2025-12-31	$15,846	13,900	0.0%	Shares	Defined	2026-02-11
2025-12-31	$15,846	13,900	—	Put	Defined	2026-02-11
No filing history on record for this holder in this stock.